Skip to main content

News

Press Release
10/03/2016
Daiichi Sankyo Company, Limited announced that it has commenced a company-initiated, large-scale registry, called ANAFIE (All Nippon AF In Elderly) Registry in Japan to study nonvalvular atrial fibrillation (hereafter, NVAF) in elderly...
Daiichi Sankyo Company, Limited announced that it has commenced a company-initiated, large-scale registry, called ANAFIE (All Nippon AF In Elderly) Registry in Japan to study nonvalvular atrial fibrillation (hereafter, NVAF) in elderly...
Daiichi Sankyo Company, Limited...
10/03/2016
EP Lab Digest
Press Release
10/03/2016
A new Roadmap to tackle Non-Valvular Atrial Fibrillation (AF), the most common and clinically significant form of cardiac arrhythmia, has been launched by the World Heart Federation (WHF). The initiative aims to help prevent AF and to...
A new Roadmap to tackle Non-Valvular Atrial Fibrillation (AF), the most common and clinically significant form of cardiac arrhythmia, has been launched by the World Heart Federation (WHF). The initiative aims to help prevent AF and to...
A new Roadmap to tackle...
10/03/2016
EP Lab Digest
Press Release
09/29/2016
BIOTRONIK announced that its new center in Singapore has begun operations. This expands the company’s existing hubs in Europe and the United States, and positions manufacturing close to growing Asia Pacific markets. BIOTRONIK has been a...
BIOTRONIK announced that its new center in Singapore has begun operations. This expands the company’s existing hubs in Europe and the United States, and positions manufacturing close to growing Asia Pacific markets. BIOTRONIK has been a...
BIOTRONIK announced that its new...
09/29/2016
EP Lab Digest
Press Release
09/29/2016
SentreHEART, Inc., the manufacturer of the LARIAT technology for catheter-based, non-implant left atrial appendage closure (LAAC), announced it has closed a $35 million Series D round of financing. Deerfield Management Company, a healthcare...
SentreHEART, Inc., the manufacturer of the LARIAT technology for catheter-based, non-implant left atrial appendage closure (LAAC), announced it has closed a $35 million Series D round of financing. Deerfield Management Company, a healthcare...
SentreHEART, Inc., the...
09/29/2016
EP Lab Digest
Press Release
09/29/2016
Roche announced the launch of the CoaguChek XS mPOC app for use with the CoaguChek XS meter. The new app makes the Bluetooth-enabled PT/INR reporting offered by CoaguChek Patient Services even more convenient and accessible by allowing...
Roche announced the launch of the CoaguChek XS mPOC app for use with the CoaguChek XS meter. The new app makes the Bluetooth-enabled PT/INR reporting offered by CoaguChek Patient Services even more convenient and accessible by allowing...
Roche announced the launch of...
09/29/2016
EP Lab Digest
Press Release
09/29/2016
CardioFocus, Inc. announced the first commercial U.S. procedure using its HeartLight® Endoscopic Ablation System for the treatment of patients with paroxysmal atrial fibrillation (AF) at The Mount Sinai Hospital in New York City. The...
CardioFocus, Inc. announced the first commercial U.S. procedure using its HeartLight® Endoscopic Ablation System for the treatment of patients with paroxysmal atrial fibrillation (AF) at The Mount Sinai Hospital in New York City. The...
CardioFocus, Inc. announced the...
09/29/2016
EP Lab Digest
Press Release
09/22/2016
SpringBoard Healthcare is now taking responses for its nationwide wage survey of nurses, technicians and specialists working in cardiac catheterization, electrophysiology and interventional radiology labs. Considered the gold standard of wage...
SpringBoard Healthcare is now taking responses for its nationwide wage survey of nurses, technicians and specialists working in cardiac catheterization, electrophysiology and interventional radiology labs. Considered the gold standard of wage...
SpringBoard Healthcare is now...
09/22/2016
EP Lab Digest
Press Release
09/19/2016
Medtronic plc announced the results of an analysis that reveals patients increasingly adhere to heart failure medications after they receive cardiac resynchronization therapy (CRT) devices. The analysis of more than 4,500 patients revealed...
Medtronic plc announced the results of an analysis that reveals patients increasingly adhere to heart failure medications after they receive cardiac resynchronization therapy (CRT) devices. The analysis of more than 4,500 patients revealed...
Medtronic plc announced the...
09/19/2016
EP Lab Digest
Press Release
09/19/2016
ARCA biopharma, Inc., a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted therapies for cardiovascular diseases, announced that is has been named as one of the winners of the Corporate...
ARCA biopharma, Inc., a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted therapies for cardiovascular diseases, announced that is has been named as one of the winners of the Corporate...
ARCA biopharma, Inc., a...
09/19/2016
EP Lab Digest
Press Release
09/13/2016
Two Medtronic plc innovations were acknowledged in updated guidelines published by the European Society of Cardiology (ESC): cryoballoon ablation for patients with diagnosed atrial fibrillation (AF), and long-term cardiac monitoring for...
Two Medtronic plc innovations were acknowledged in updated guidelines published by the European Society of Cardiology (ESC): cryoballoon ablation for patients with diagnosed atrial fibrillation (AF), and long-term cardiac monitoring for...
Two Medtronic plc innovations...
09/13/2016
EP Lab Digest